Asano Y - Search Results

1

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial.

Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Asano Y, Okiyama N, Kodera M, Hasegawa M, Sato S. Ebata S, et al. Among authors: asano y. Lancet Rheumatol. 2021 Jul;3(7):e489-e497. doi: 10.1016/S2665-9913(21)00107-7. Epub 2021 May 26. Lancet Rheumatol. 2021. PMID: 38279402

2

A case of dermatomyositis with "liver disease associated with rheumatoid diseases" positive for anti-liver-kidney microsome-1 antibody.

Noda S, Asano Y, Tamaki Z, Takekoshi T, Sugaya M, Sato S. Noda S, et al. Among authors: asano y. Clin Rheumatol. 2010 Aug;29(8):941-3. doi: 10.1007/s10067-010-1397-3. Epub 2010 Feb 24. Clin Rheumatol. 2010. PMID: 20179980

3

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.

Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S. Yoshizaki A, et al. Among authors: asano y. Arthritis Rheum. 2010 Aug;62(8):2476-87. doi: 10.1002/art.27498. Arthritis Rheum. 2010. PMID: 20506342 Free article.

4

Serum CCL23 levels are increased in patients with systemic sclerosis.

Yanaba K, Yoshizaki A, Muroi E, Ogawa F, Asano Y, Kadono T, Sato S. Yanaba K, et al. Among authors: asano y. Arch Dermatol Res. 2011 Jan;303(1):29-34. doi: 10.1007/s00403-010-1078-8. Epub 2010 Sep 8. Arch Dermatol Res. 2011. PMID: 20824279

5

Serum levels of soluble CD21 in patients with systemic sclerosis.

Tomita M, Kadono T, Yazawa N, Kawashima T, Tamaki Z, Ashida R, Ohmatsu H, Asano Y, Sugaya M, Kubo M, Ihn H, Tamaki K, Sato S. Tomita M, et al. Among authors: asano y. Rheumatol Int. 2012 Feb;32(2):317-21. doi: 10.1007/s00296-010-1610-3. Epub 2010 Oct 30. Rheumatol Int. 2012. PMID: 21052675

6

Altered dynamics of transforming growth factor β(TGF-β) receptors in scleroderma fibroblasts.

Asano Y, Ihn H, Jinnin M, Tamaki K, Sato S. Asano Y, et al. Ann Rheum Dis. 2011 Feb;70(2):384-7. doi: 10.1136/ard.2009.127811. Epub 2010 Nov 15. Ann Rheum Dis. 2011. PMID: 21081531

7

Disseminated cutaneous and visceral Kaposi's sarcoma in a patient with rheumatoid arthritis receiving corticosteroids and tacrolimus.

Taniguchi T, Asano Y, Kawaguchi M, Kogure A, Mitsui H, Sugaya M, Sato S. Taniguchi T, et al. Among authors: asano y. Mod Rheumatol. 2011 Jun;21(3):309-12. doi: 10.1007/s10165-010-0389-0. Epub 2010 Dec 28. Mod Rheumatol. 2011. PMID: 21188451

8

The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis.

Miyagaki T, Asano Y, Shibata S, Ohno Y, Tsunemi Y, Saeki H, Tamaki K, Sato S. Miyagaki T, et al. Among authors: asano y. Mod Rheumatol. 2011 Aug;21(4):406-9. doi: 10.1007/s10165-010-0404-5. Epub 2011 Jan 13. Mod Rheumatol. 2011. PMID: 21229374

9

Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Yanaba K, et al. Among authors: asano y. Clin Rheumatol. 2011 Jun;30(6):825-30. doi: 10.1007/s10067-011-1686-5. Epub 2011 Jan 19. Clin Rheumatol. 2011. PMID: 21246230

10

Ultraviolet light-induced Köbner phenomenon contributes to the development of skin eruptions in multicentric reticulohistiocytosis.

Taniguchi T, Asano Y, Okada A, Sugaya M, Sato S. Taniguchi T, et al. Among authors: asano y. Acta Derm Venereol. 2011 Mar;91(2):160-3. doi: 10.2340/00015555-0961. Acta Derm Venereol. 2011. PMID: 21279300 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,548 results

Search Page

Filters